Effects of probiotics on the recurrence of bacterial vaginosis: A review

Journal of Lower Genital Tract Disease

Volumn 18, Issue 1, 2014, Pages 79-86

  Homayouni, Aziz ^a   Bastani, Parvin ^b   Ziyadi, Somayeh ^a   Mohammad Alizadeh Charandabi, Sakineh ^a   Ghalibaf, Morad ^c   Mortazavian, Amir Mohammad ^c,d   Mehrabany, Elnaz Vaghef ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

bacterial vaginosis; probiotics; urinary tract infection

Indexed keywords

ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, ORAL; CONTROLLED CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS FERMENTUM; LACTOBACILLUS RHAMNOSUS; PROBIOTICS; RECURRENCE; TREATMENT OUTCOME; VAGINOSIS, BACTERIAL;

EID: 84894095396     PISSN: 10892591     EISSN: 15260976     Source Type: Journal    
DOI: 10.1097/LGT.0b013e31829156ec     Document Type: Review

References (69)

1. Eschenbach DA. History and review of bacterial vaginosis. Am J Obstet Gynecol 1993;169:441-5.
2. Romoren M, Velauthapillai M, Rahman M, Subdy J, Klouman E,Hjortdahl P. Trichomoniasis and bacterial vaginosis in pregnancy: Inadequately managed with the syndromic approach. Bull World Health Organ 2007;85:297-304.
3. Mohanty S, Sood S, Kapil A, Mittal S. Interobserver variation in the interpretation of Nugent scoring method for diagnosis of bacterial vaginosis. Indian JMed Res 2010;131:88-91.
4. Parent D, Bossens M, Bayot D, Kirkpatrick C, Graf F. Therapy of bacterial vaginosis using exogenously-applied Lactobacillus aciophili and a low dose of estriol: A placebocontrolled multicentric clinical trial. Arzneimitell Forschung 1996;46:68-73.
5. Hantoushzadeh S, Golshahi F, Javadian P, Khazardoost S, Aram S, Hashemi S, et al. Comparative efficacy of probiotic yoghurt and clindamycin in treatment of bacterial vaginosis in pregnant women: A randomized clinical trial. J Matern Fetal Neonatal Med 2012;25:1021-4.
6. Nelson DB,Macones G. Bacterial vaginosis in pregnancy: Current findings and future directions. Epidemiol Rev 2002; 24:102-8.
7. Hay PE. Bacterial vaginosis and miscarriage. Curr Opin Infect Dis 2004;17:41-4.
8. Hoyme UB, Huebner J. Prevention of preterm birth is possible by vaginal pH screening, early diagnosis of bacterial vaginosis or abnormal vaginal flora and treatment. Gynecol Obstet Invest 2010;70:286-90.
9. Wilson JD, Ralph SG, Rutherford AJ. Rates of bacterial vaginosis in women undergoing in vitro fertilisation for different types of infertility. BJOG 2002;109:714-7.
10. Cauci S, Driussi S, De Santo D, Penacchioni P, Iannicelli T, lanzafame P, et al. Prevalence of bacterial vaginosis and vaginal flora changes in peri-and postmenopausal women. J Clin Microbiol 2002;40:2147-52.
11. Sweet RL. Role of bacterial vaginosis in pelvic inflammatory disease. Clin Infect Dis 1995;20:271-5.
12. Hauth JC, Goldenberg RL, AndrewsWW, DuBardMB, Copper RL. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med 1995;333:1732-6.
13. Reid G, Bocking A. The potential for probiotics to prevent bacterial vaginosis and preterm labor. Am J Obstet Gynecol 2003;189:1202-8.
14. Cherpes TL, MelanMA, Kant JA, Cosentino LA,Meyn LA, Hillier SL. Genital tract shedding of herpes simplex virus type 2 in women: Effects of hormonal contraception, bacterial vaginosis, and vaginal group B Streptococcus colonization. Clin Infect Dis 2005;40:1422-8.
15. Marrazzo JM. Evolving issues in understanding and treating bacterial vaginosis. Expert Rev Anti infect Ther 2004; 2:913-22.
16. Cunningham-Rundles S, Ahrne S, Johann-Liang R, Abuav R, Dunn-Navarra AM, Grassey C, et al. Effect of probiotic bacteria on microbial host defense, growth, and immune function in human immunodeficiency virus type-1 infection. Nutrients 2011;3:1042-70.
17. Reid G. Probiotic agents to protect the urogenital tract against infection. Am J Clin Nutr 2001;73(suppl 2):437-43S.
18. Fethers K, Fairley CK, Hocking J, Gurrin LC, Bradshow CS. Sexual risk factors and bacterial vaginosis: A systematic review and meta-analysis. Clin Infect Dis 2008;47:1426-35.
19. Anukam KC, Osazuwa E, Osemene GI, Ehigiagbe F, Bruce AW, Reid G. Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes Infect 2006; 8:2772-6.
20. Oduyebo OO, Anorlu RI, Ogunsola T. Effects of antimicrobial therapy on bacterial vaginosis in non-pregnant women. Cochrane Database Syst Rev 2009;(3):CD004052.
21. Joesoef MR, Schmid GP, Hillier SL. Bacterial vaginosis review of treatment options and potential clinical indications for therapy. Clin Infect Dis 1999;28:57-65.
22. Andreeva PM, Omar HA. Effectiveness of current therapy of bacterial vaginosis. Int J Adolesc Med Health 2002; 14:145-8.
23. Champagne CP, Ross RP, Saarela M, Hansen KF, Charalampopoulos D. Recommendations for the viability assessment of probiotics as concentrated cultures and in food matrices. Int j Food Microbiol 2011;149:185-93.
24. Salminen S, Bouley C, Boutron-Ruault MC, Cummings JH, Franck A, Gibson GR, et al. Functional food science and gastrointestinal physiology and function. Br J Nutr 1998; 80:147-71.
25. Andersson H, Asp NG, Bruce A, Roos S, Wadstrom T, Wold AE. Health effects of probiotics and prebiotics: A literature review on human studies. Food Nutr Res 2001;45:58-75.
26. Coudeyras S, Jugie G, Vermerie M, Forestier C. Adhesion of human probiotic Lactobacillus rhamnosus to cervical and vaginal cells and interaction with vaginosis-associated pathogens. Infect Dis Obstet Gynecol 2008;2008:549640.
27. Brink M, Senekal M, Dicks LMT. Market and product assessment of probiotic/prebioticYcontaining functional foods and supplements manufactured in South Africa. J Afr Med J 2005;95:114-9.
28. Lye HS, Kuan CY, Ewe JA, Fung WY, Liong MT. The improvement of hypertension by probiotics: Effects on cholesterol, diabetes, renin, and phytoestrogens. Int J Mol Sci 2009;10: 3755-75.
29. Antonio MA, Hillier SL. DNA fingerprinting of Lactobacillus crispatus strain CTV-05 by repetitive element sequence-based PCR analysis in a pilot study of vaginal colonization. J Clin Microbiol 2003;41:1881-7.
30. Homayouni Rad A, Vaghef E, Alipoor B, Vaghef L, Javadi M. Do probiotics act more efficiently in foods than in supplements Nutrition 2012;28:733-6.
31. Homayouni A, Azizi A, Ehsani MR, Yarmand MS, Razavi SH. Effect of microencapsulation and resistant starch on the probiotic survival and sensory properties of synbiotic ice cream. Food Chemistry 2008;111:50-5.
32. Mastromarino P, Macchia S, Meggiorini L, Trinchieri V, Mosca L, Perluigi M, et al. Effectiveness of Lactobacilluscontaining vaginal tablets in the treatment of symptomatic bacterial vaginosis. Clin Microbiol Infect 2009;15:67-74.
33. Reid G, Beuerman D, Heinemann C, Bruce AW. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol Med Microbiol 2001;32: 37-41.
34. Reid G, Bruce AW. Urogenital infections in women: Can probiotics help Postgrad Med J 2003;79:428-32.
35. Antonio MA, Rabe LK, Hillier SL. Colonization of the rectum by Lactobacillus species and decreased risk of bacterial vaginosis. J Infect Dis 2005;192:394-8.
36. Anukam K, Osazuwa E, Ahonkhai I, NgwuM, Osemene G, Bruce AW, et al. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: Randomized, double-blind, placebo controlled trial. Microbes Infect 2006; 8:1450-4.
37. Goldin BR, Gorbach SL. Clinical indications for probiotics: An overview. Clin Infect Dis 2008;46:96-100.
38. Cribby S, TaylorM, Reid G. Vaginal microbiota and the use of probiotics. Interdiscip Perspect Infect Dis 2008;2008: 256490.
39. Reid G, Bruce AW. Selection of Lactobacillus strains for urogenital probiotic applications. J Infect Dis 2001;183: 77-80.
40. Bradshaw CS, Pirotta M, De Guingand D, Hocking JS, Morton AN, Garland SM, et al. Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: Randomised placebo-controlled double-blind trial. PLoS One 2012;7:e34540.
41. Larsson PG, Forsum U. Bacterial vaginosisVa disturbed bacterial flora and treatment enigma. APMIS 2005;113:305-16.
42. Marcone V, Calzolari E, Bertini M. Effectiveness of vaginal administration of Lactobacillus rhamnosus following conventional metronidazole therapy: How to lower the rate of bacterial vaginosis recurrences. NewMicrobiol 2008;31:429-33.
43. Neri A, Sabah G, Samra Z. Bacterial vaginosis in pregnancy treated with yoghurt. Acta Obst Gynecol Scand 1993;72:17-9.
44. Shalev E, Battino S, Weiner E, Colodner R, Keness Y. Ingestion of yogurt containing Lactobacillus acidophilus compared with pasteurized yogurt as prophylaxis for recurrent candidal vaginitis and bacterial vaginosis. Arch Fam Med 1996;5:593-6.
45. YaW, Reifer C, Miller LE. Efficacy of vaginal probiotic capsules for recurrent bacterial vaginosis: A double-blind, randomized, placebocontrolled study. Am J Obstet Gynecol 2010;203:120-5.
46. Eriksson K, Carlsson B, Forsum U, Larsson PG. A double-blind treatment study of bacterial vaginosis with normal vaginal lactobacilli after an open treatment with vaginal clindamycin ovules. Acta Derm Venereol 2005;85:42-6.
47. Ozkinay E, Terek MC, Yayci M, Kaiser R, Grob P, Tuncay G. The effectiveness of live lactobacilli in combination with low dose oestriol (Gynoflor) to restore the vaginal flora after treatment of vaginal infections. Br J Obstet Gynaecol 2005;112:234-40.
48. Ehrstrom S, Daroczy K, Rylander E, Samuelsson C, Johannesson U, Anzén B, et al. Lactic acid bacteria colonization and clinical outcome after probiotic supplementation in conventionally treated bacterial vaginosis and vulvovaginal candidiasis. Microbes Infect 2010;12:691-9.
49. Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, Niafar M, Asghari-Jafarabadi M, Mofid V, et al. Effect of probiotic yoghurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with Type 2 diabetes mellitus. J Dairy Sci 2011;94:3288-94.
50. Reid G, Bruce AW, Fraser N, Heinemann C, Owen J, Henning B. Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol 2001;30:49-52.
51. Thulkar J, Kriplani A, Agarwal N . Probiotic and metronidazole treatment for recurrent bacterial vaginosis. Int J Gynaecol Obstet 2010;108:251-2.
52. Marcone V, Rocca G, Lichtner M, Calzolari E. Longterm vaginal administration of Lactobacillus rhamnosus as a complementary approach to management of bacterial vaginosis. Int J Gynecol Obstet 2010;110:223-6.
53. Hemalatha R, Mastromarino P, Ramalaxmi BA, Balakrishna NV, Sesikeran B. Effectiveness of vaginal tablets containing lactobacilli versus pH tablets on vaginal health and inflammatory cytokines: A randomized, double-blind study. Eur J Clin Microbiol Infect Dis 2012;31:3097-105.
54. Donders GG, Van Bulck B, Van de Walle P, Kaiser RR, Pohlig G, Gonser S, et al. Effect of lyophilized lactobacilli and 0.03 mg estriol (Gynoflor\) on vaginitis and vaginosis with disrupted vaginal microflora: A multicenter, randomized, single-blind, active-controlled pilot study. Gynecol Obstet Invest 2010;70:264-72.
55. Rossi A, Rossi T, Bertini M, Caccia G. The use of Lactobacillus rhamnosus in the therapy of bacterial vaginosis. Evaluation of clinical efficacy in a population of 40 women treated for 24 months. Arch Gynecol Obstet 2010;281:1065-9.
56. Mastromarino P, Brigidi P, Macchia S, Maggi L, Pirovano F, Trinchieri V, et al. Characterization and selection of vaginal Lactobacillus strains for the preparation of vaginal tablets. J Appl Microbiol 2002;93:884-93.
57. Petricevic L, Unger FM, Viernstein H, Kiss H. Randomized, double-blind, placebo-controlled study of oral lactobacilli to improve the vaginal flora of postmenopausal women. Eur J Obstet Gynecol Reprod Biol 2008;141:54-7.
58. ValentinaM, EttoreC,Marco B. Effectiveness of vaginal administration of Lactobacillus rhamnosus following conventional metronidazole therapy: How to lower the rate of bacterial vaginosis recurrences. New Microbiologica 2008;31:429-33.
59. Stapleton AE, AU-Yeyng M, Hooton TM, Fredriks DN, Roberts PL. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis 2011;52:1212-7.
60. McLean NW, Rosenstein IJ. Characterisation and selection of a Lactobacillus species to re-colonise the vagina of women with recurrent bacterial vaginosis. J Med Microbiol 2000;49:543-52.
61. Falagas ME, Betsi GI, Athanasiou S. Probiotics for the treatment of women with bacterial vaginosis. Clin Microbiol Infect 2007;13:657-64.
62. Reid G, Bruce AW, Taylor M. Instillation of Lactobacillus and stimulation of indigenous organisms to prevent recurrence of urinary tract infections. Microecol Ther 1995;23:32-45.
63. Devillard E, Burton JP, Reid G. Complexity of vaginal microflora as analyzed by PCR denaturing gradient gel electrophoresis in a patient with recurrent bacterial vaginosis. Infect Dis Obstet Gynecol 2005;13:25-31.
64. Ngugi BM, Hemmerling A, Bukusi EA, Kikuvi G, Gikunju J, Shiboski S, et al. Effects of bacterial vaginosisY associated bacteria and sexual intercourse on vaginal colonization with the probiotic Lactobacillus crispatus CTV-05. Sex Transm Dis 2011;38:1020-7.
65. Alvarez-Olmos MI, Barousse MM, Rajan L, Van Der Pol BJ, Fortenberry D, Orr D, et al. Vaginal lactobacilli in adolescents: Presence and relationship to local and systemic immunity, and to bacterial vaginosis. Sex Transm Dis 2004; 31:393-400.
66. Gardiner GE, Heinemann C, Baroja ML, Bruce AW, Beuerman D, Madrenas J, et al. Oral administration of the probiotic combination Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 for human intestinal applications. Int Dairy J 2002;12:191-6.
67. Homayouni A. Letter to the editor. Food Chem 2009; 114:1073.
68. Reid G, Burton J, Hammond JA, Bruce AW. Nucleic acid based diagnosis of bacterial vaginosis and improved management using probiotic lactobacilli. J Med Food 2004;7:223-8.
69. Reid G, Charbonneau D, Erb J, Kochanowski B, Beuerman D, Poehner R, et al. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: Randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol 2003;35:131-4.